Smiths Detection Technology Expert Appears before U.S. Senate Caucus on International Narcotics Control
EDGEWOOD, Md.--(BUSINESS WIRE)--Oct 2, 2018--Dr. Michael Frunzi, Product Manager, Optical Products for Smiths Detection, testified on technology’s role in interdicting opioids and other dangerous narcotics. At a hearing entitled “ Stopping the Poison Pills: Combatting the Trafficking of Illegal Fentanyl from China ”, Dr. Frunzi relayed to members of the U.S. Senate Caucus on International Narcotics Control, how advancements in technology help protect the health and safety of the public, as well as methods to intercept the illegal passage of dangerous substances, such as illicit fentanyl.
“It is unlikely that the public health threat posed by the opioid epidemic will be ameliorated anytime soon. Only a combination of law enforcement, community outreach, political overtures and medical intervention will eventually solve this massive problem. In the meantime, fentanyl and the harm it can cause to users, responders and the general public will persist,” Dr. Frunzi said in his prepared remarks. He also stated, “Smiths Detection will continue to move technology forward to provide flexible, innovative solutions to these and other threats, to safeguard society, protect life and support the free flow of trade.”
Dr. Michael Frunzi is a senior scientist at Smiths Detection, where he has worked since 2011. He graduated from Saint Joseph’s University before earning his Ph.D. in Physical Chemistry from Yale University. Dr. Frunzi did his post-doctoral work at the Turro Lab at Columbia University, where he conducted research using a range of optical techniques including fourier-transform infrared (FTIR) and RAMAN spectroscopy.
Dr. Frunzi’s testimony highlighted three key recommendations to support the development and use of narcotics detection equipment to help combat the threat of imported opioids:Establish a Public/Private working group aimed to disrupt foreign opioid shipments into the U.S. and release recommendations in about 180 days. Support passage of S. 2763, “The Power Act,” with a clear appropriation line for the next five fiscal years to help fund portable chemical screening devices for law enforcement. Budgeting for Operations & Maintenance (O&M) and refresh of technology for future funds or grants that are awarded to state and local authorities.
For more information on Smiths Detection technologies that address the opioid crisis, please visit: https://www.smithsdetection.com/preventfentanylexposure/
For more information on the U.S. Senate Caucus on International Narcotics Control, please visit: https://www.drugcaucus.senate.gov/HomePage
About Smiths Detection
Smiths Detection, part of Smiths Group, is a global leader in threat detection and screening technologies for the aviation, ports and borders, urban security and defense markets. With more than 40 years of field-tested experience, we deliver the solutions needed to protect society from the threat and illegal passage of explosives, prohibited weapons, contraband, toxic chemicals and narcotics.
Our goal is simple – to provide security, peace of mind and freedom of movement, upon which the world depends. For more information visit www.smithsdetection.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181002005790/en/
CONTACT: Blueprint Communications
Chad Kolton, 571-414-0730
Dana Knox-Gower, 203-482-6752
Communications and Marketing - Americas
KEYWORD: UNITED KINGDOM UNITED STATES MEXICO EUROPE ASIA PACIFIC NORTH AMERICA CENTRAL AMERICA CANADA CHINA DISTRICT OF COLUMBIA MARYLAND
INDUSTRY KEYWORD: TECHNOLOGY OTHER TECHNOLOGY TRANSPORT SECURITY HEALTH OTHER TRANSPORT PUBLIC POLICY/GOVERNMENT CONGRESSIONAL NEWS/VIEWS LAW ENFORCEMENT/EMERGENCY SERVICES HOMELAND SECURITY PHARMACEUTICAL OTHER GOVERNMENT OTHER POLICY ISSUES PUBLIC POLICY WHITE HOUSE/FEDERAL GOVERNMENT DEFENSE OTHER DEFENSE
SOURCE: Smiths Detection
Copyright Business Wire 2018.
PUB: 10/02/2018 12:00 PM/DISC: 10/02/2018 12:01 PM